-
Dr Ranjit Barshikar honoured with Quality Champion – GOLD award by QCI and NBQP
expresspharma
March 03, 2021
It is in recognition of his “Outstanding professional achievements, commitments and contributions in improving quality in the pharma industry.”
-
AustralaSian COVID-19 trial opens in India
expresspharma
March 02, 2021
ASCOT has partnered with the George Institute for Global Health to oversee the trial in India.
-
Liability for COVID vaccines in India: Where does the buck stop?
expresspharma
March 02, 2021
A month into Indias country-wide vaccination drive that began in January 2021, and we have reportedly seen the death of 27 people already, including that of a 24-year-old medical intern, a mere 11 days after her vaccination.
-
NATCO launches Brivaracetam tablets in India
expresspharma
March 01, 2021
Natco Pharma announced the launch of Brivaracetam tablets under brand BRECITA in India.
-
Piyush Goyal asks pharma industry to strive for quality, absorb global experiences
expresspharma
February 26, 2021
He said that we can provide the world with the confidence that if there is anything to do with health, then India is the place to look at as a one-stop solution.
-
Cabinet nod for pharma PLI Scheme
expresspharma
February 25, 2021
The scheme is also expected to bring in investment of Rs.15,000 crore in the pharma sector.
-
India sends first COVID-19 vaccine shipment to Africa under COVAX programme
expresspharma
February 24, 2021
India sent its first shipment of locally made COVID-19 vaccines to the WHO-backed equitable vaccine distribution network COVAX on Tuesday.
-
Sun Pharma to launch entire range of Brivaracetam for epilepsy treatment in India
expresspharma
February 24, 2021
Brivaracetam is an anti-epileptic drug (AEDs) with fast onset of action and promising efficacy.
-
Vaccination offers consistent long term protection: Experts
expresspharma
February 23, 2021
Vaccination offers much stronger immune response than natural infection, and therefore is the key to controlling the spread of the disease.
-
Serum Institute of India says prioritising domestic vaccine needs
expresspharma
February 22, 2021
Many low-and middle-income countries, ranging from Bangladesh to Brazil, are depending on SII’s AstraZeneca vaccine, branded COVISHIELD.